Charles L. Sentman

9.4k total citations · 1 hit paper
115 papers, 7.6k citations indexed

About

Charles L. Sentman is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Charles L. Sentman has authored 115 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Immunology, 53 papers in Oncology and 9 papers in Hematology. Recurrent topics in Charles L. Sentman's work include Immune Cell Function and Interaction (98 papers), T-cell and B-cell Immunology (59 papers) and CAR-T cell therapy research (51 papers). Charles L. Sentman is often cited by papers focused on Immune Cell Function and Interaction (98 papers), T-cell and B-cell Immunology (59 papers) and CAR-T cell therapy research (51 papers). Charles L. Sentman collaborates with scholars based in United States, Sweden and Switzerland. Charles L. Sentman's co-authors include Tong Zhang, Amorette Barber, Charles R. Wira, Osami Kanagawa, Stanley J. Korsmeyer, John R. Shutter, David M. Hockenbery, Tiffany A. Coupet, Mikael Eriksson and Amelia M. Huehls and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Charles L. Sentman

114 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes

1991 1.1k citations Charles L. Sentman et al. profile →

Peers

Charles L. Sentman

IMMUN

ONCOL

GENET

Eckhart Kämpgen Germany

Peter L. Stern United Kingdom

Ana C. Anderson United States

Cornelis J.M. Melief Netherlands

Thorbald van Hall Netherlands

Stephen Haskill United States

Paloma Sánchez‐Mateos Spain

David Buck United Kingdom

Silvano Ferrini Italy

Claudia Cantoni Italy

Eckhart Kämpgen Germany

Charles L. Sentman

7.9k ×1.5

IMMUN

2.4k ×0.7

ONCOL

2.7k ×1.5

152 ×0.2

547 ×1.0

GENET

Citations per year, relative to Charles L. Sentman Charles L. Sentman (= 1×) peers Eckhart Kämpgen

Countries citing papers authored by Charles L. Sentman

Since Specialization

Citations

This map shows the geographic impact of Charles L. Sentman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles L. Sentman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles L. Sentman more than expected).

Fields of papers citing papers by Charles L. Sentman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles L. Sentman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles L. Sentman. The network helps show where Charles L. Sentman may publish in the future.

Co-authorship network of co-authors of Charles L. Sentman

This figure shows the co-authorship network connecting the top 25 collaborators of Charles L. Sentman. A scholar is included among the top collaborators of Charles L. Sentman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles L. Sentman. Charles L. Sentman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cook, W. James, et al.. (2022). Superkine IL-2 and IL-33 Armored CAR T Cells Reshape the Tumor Microenvironment and Reduce Growth of Multiple Solid Tumors. Cancer Immunology Research. 10(8). 962–977. 44 indexed citations

Look, Thomas, Patrick Roth, Steve Pascolo, et al.. (2022). Multifunctional mRNA-Based CAR T Cells Display Promising Antitumor Activity Against Glioblastoma. Clinical Cancer Research. 28(21). 4747–4756. 55 indexed citations

Weiß, Tobias, Michael Weller, Matthias Gückenberger, Charles L. Sentman, & Patrick Roth. (2017). NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma. Cancer Research. 78(4). 1031–1043. 231 indexed citations

Stephan, Sirkka B., et al.. (2014). Biopolymer implants enhance the efficacy of adoptive T-cell therapy. Nature Biotechnology. 33(1). 97–101. 367 indexed citations

Spear, Paul W., Amorette Barber, & Charles L. Sentman. (2013). Collaboration of chimeric antigen receptor (CAR)-expressing T cells and host T cells for optimal elimination of established ovarian tumors. OncoImmunology. 2(4). e23564–e23564. 47 indexed citations

Zhang, Tong & Charles L. Sentman. (2011). Cancer Immunotherapy Using a Bispecific NK Receptor Fusion Protein that Engages both T Cells and Tumor Cells. Cancer Research. 71(6). 2066–2076. 56 indexed citations

Barber, Amorette, et al.. (2009). Chimeric NKG2D Expressing T Cells Eliminate Immunosuppression and Activate Immunity within the Ovarian Tumor Microenvironment. The Journal of Immunology. 183(11). 6939–6947. 85 indexed citations

Barber, Amorette & Charles L. Sentman. (2009). Chimeric NKG2D T Cells Require Both T Cell- and Host-Derived Cytokine Secretion and Perforin Expression to Increase Tumor Antigen Presentation and Systemic Immunity. The Journal of Immunology. 183(4). 2365–2372. 29 indexed citations

Huarte, Eduardo, Juan R. Cubillos‐Ruiz, Yolanda C. Nesbeth, et al.. (2008). Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity. Cancer Research. 68(18). 7684–7691. 96 indexed citations

10.

Barber, Amorette, Tong Zhang, Leslie R. DeMars, et al.. (2007). Chimeric NKG2D Receptor–Bearing T Cells as Immunotherapy for Ovarian Cancer. Cancer Research. 67(10). 5003–5008. 86 indexed citations

11.

Zhang, Tong, Amorette Barber, & Charles L. Sentman. (2007). Chimeric NKG2D–Modified T Cells Inhibit Systemic T-Cell Lymphoma Growth in a Manner Involving Multiple Cytokines and Cytotoxic Pathways. Cancer Research. 67(22). 11029–11036. 70 indexed citations

12.

Zhang, Tong, Amorette Barber, & Charles L. Sentman. (2006). Generation of Antitumor Responses by Genetic Modification of Primary Human T Cells with a Chimeric NKG2D Receptor. Cancer Research. 66(11). 5927–5933. 109 indexed citations

13.

Wahle, Joseph, et al.. (2006). Cutting Edge: Dominance by an MHC-Independent Inhibitory Receptor Compromises NK Killing of Complex Targets. The Journal of Immunology. 176(12). 7165–7169. 30 indexed citations

14.

Grundy, Martin & Charles L. Sentman. (2006). Immunodeficient mice have elevated numbers of NK cells in non-lymphoid tissues. Experimental Cell Research. 312(19). 3920–3926. 22 indexed citations

15.

Fahlén, Linda, Urban Lendahl, & Charles L. Sentman. (2001). MHC Class I-Ly49 Interactions Shape the Ly49 Repertoire on Murine NK Cells. The Journal of Immunology. 166(11). 6585–6592. 35 indexed citations

16.

Sjöström, Anna, Mikael Eriksson, Cristina Cerboni, et al.. (2001). Acquisition of External Major Histocompatibility Complex Class I Molecules by Natural Killer Cells Expressing Inhibitory Ly49 Receptors. The Journal of Experimental Medicine. 194(10). 1519–1530. 80 indexed citations

17.

Eriksson, Mikael, Guenther Leitz, Erik Fällman, et al.. (1999). Inhibitory Receptors Alter Natural Killer Cell Interactions with Target Cells Yet Allow Simultaneous Killing of Susceptible Targets. The Journal of Experimental Medicine. 190(7). 1005–1012. 80 indexed citations

18.

Olsson-Alheim, M Y, Margarita Salcedo, Hans‐Gustaf Ljunggren, Klas Kärre, & Charles L. Sentman. (1997). NK cell receptor calibration: effects of MHC class I induction on killing by Ly49Ahigh and Ly49Alow NK cells. The Journal of Immunology. 159(7). 3189–3194. 45 indexed citations

19.

Sentman, Charles L., et al.. (1995). Glycosylphosphatidylinositol‐linked D^b does not induce an influenza‐specific cytotoxic T lymphocyte response or recycle membrane‐bound peptides. European Journal of Immunology. 25(4). 1121–1124. 19 indexed citations

20.

Sentman, Charles L., John Hackett, Thomas A. Moore, et al.. (1989). Pan Natural Killer Cell Monoclonal Antibodies and Their Relationship to the NK1.1 Antigen. Hybridoma. 8(6). 605–614. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact